Anaplastic Oligodendroglioma: A New Treatment Paradigm and Current Controversies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anaplastic Oligodendroglioma: A New Treatment Paradigm and Current Controversies
Authors
Keywords
Anaplastic oligodendroglioma, Irradiation, Chemotherapy, Procarbazine, lomustine and vincristin, Temozolomide
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 14, Issue 4, Pages 505-513
Publisher
Springer Nature
Online
2013-08-01
DOI
10.1007/s11864-013-0251-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular neuro-oncology in clinical practice: a new horizon
- (2013) Michael Weller et al. LANCET ONCOLOGY
- Bevacizumab Alone or in Combination with Irinotecan in Recurrent WHO Grade II and Grade III Gliomas
- (2012) Katharina Seystahl et al. EUROPEAN NEUROLOGY
- Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951
- (2012) Lale Erdem-Eraslan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Initial treatment patterns over time for anaplastic oligodendroglial tumors
- (2012) K. S. Panageas et al. NEURO-ONCOLOGY
- A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma
- (2011) T. N. Kreisl et al. NEURO-ONCOLOGY
- International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
- (2011) A. B. Lassman et al. NEURO-ONCOLOGY
- Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
- (2011) C. Bettegowda et al. SCIENCE
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
- (2010) Martin J. van den Bent ACTA NEUROPATHOLOGICA
- Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma
- (2009) Marc C. Chamberlain et al. CANCER
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis
- (2009) Abraham Tsitlakidis et al. JOURNAL OF NEUROSURGERY
- Bevacizumab and irinotecan for recurrent oligodendroglial tumors
- (2009) S. Taillibert et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search